Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Three, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of the Travelers' Diarrhea Vaccine System

NCT00993681 is registered in ClinicalTrials.gov with Intercell USA, Inc. as lead sponsor.

NCT NCT00993681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00993681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Three, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of the Travelers' Diarrhea Vaccine System
Lead sponsor
Intercell USA, Inc.
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2009
Completion date
April 30, 2011
Enrollment
2,036 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

travelers' diarrhea